LOS ANGELES, May 23, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced today participation...
News Ticker
- [ June 5, 2023 ] Amgen continues to target mid-December deadline for Horizon deal close Los Angeles Biotech News
- [ June 5, 2023 ] Akero’s NASH candidate reduces liver fat in patients taking a GLP-1 Los Angeles Biotech News
- [ June 5, 2023 ] Pharmaceutical Visual Inspector Technician – MedisourceRx – Los Alamitos, CA Los Angeles Biotech Jobs
- [ June 5, 2023 ] Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023 Los Angeles Biotech News
- [ June 5, 2023 ] Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health Los Angeles Biotech News
Copyright © 2021 Biotech Networks, LLC
